Envestnet Portfolio Solutions Inc. Raises Stock Position in Danaher Corporation $DHR

Envestnet Portfolio Solutions Inc. raised its stake in shares of Danaher Corporation (NYSE:DHR) by 4.6% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 78,933 shares of the conglomerate’s stock after acquiring an additional 3,436 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Danaher were worth $15,592,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of DHR. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% in the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock worth $25,000 after buying an additional 99 shares in the last quarter. Sierra Ocean LLC grew its position in shares of Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. Red Tortoise LLC increased its holdings in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in Danaher during the first quarter worth approximately $31,000. Finally, Dunhill Financial LLC boosted its stake in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock worth $34,000 after buying an additional 67 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the company’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.20% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on DHR shares. Guggenheim reissued a “buy” rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Robert W. Baird increased their price target on shares of Danaher from $225.00 to $226.00 and gave the company an “outperform” rating in a research note on Friday, July 18th. Redburn Partners set a $220.00 price target on shares of Danaher in a research report on Wednesday, October 8th. Scotiabank upgraded Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective on the stock in a report on Friday, July 11th. Finally, UBS Group cut their target price on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research note on Wednesday, July 23rd. Seventeen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $244.60.

Danaher Stock Up 1.4%

Shares of DHR opened at $205.36 on Tuesday. The company’s 50-day simple moving average is $200.82 and its 200-day simple moving average is $197.06. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The stock has a market capitalization of $147.05 billion, a PE ratio of 43.69, a P/E/G ratio of 2.88 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the prior year, the firm earned $1.72 EPS. The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.